Plasma Interleukin-6 Levels in Patients with Cirrhosis Relationship to Endotoxemia, Tumor Necrosis Factor-α, and Hyperdynamic Circulation

References

• Genecin P, Groszmann R J. Portal hypertension. Diseases of the liver. 7th ed, E Schiff, L Schiff. Lippincott, Philadelphia 1993; 935–73
   Google Scholar
• Colombato L A, Albillos A, Groszmann R J. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats. Hepatology 1991; 15: 323–8
   Google Scholar
• Albillos A, Colombato L A, Groszmann R J. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992; 102: 931–5
   PubMed Web of Science ®Google Scholar
• Pizcueta M P, Piqué J M, Bosch J, Whittle B JR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184–90
   PubMed Web of Science ®Google Scholar
• Lee F Y, Colombato L A, Albillos A, Groszmann R J. No-Nitro-Larginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17: 84–90
   PubMed Web of Science ®Google Scholar
• Lumsden A B, Henderson J M, Kutner M H. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8: 232–6
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode J C, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12: 162–9
   PubMed Web of Science ®Google Scholar
• Bigatello L M, Broitman S A, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987; 82: 11–5
   PubMed Web of Science ®Google Scholar
• Lin R S, Lee F Y, Lee S D, Tsai Y T, Lin H C, Lu R H, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995; 22: 165–72
   PubMed Web of Science ®Google Scholar
• Julou-Schaeffer G, Gray G A, Fleming I, Schott C, Parratt J R, Stoclet J C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259: H1038–43
   PubMed Web of Science ®Google Scholar
• Rees D D, Cellek S, Palmer R MJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 541–7
   PubMed Web of Science ®Google Scholar
• Suffredini A F, Fromm R E, Parker M M, Brenner M, Kovacs J A, Wesley R A, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280–7
   PubMed Web of Science ®Google Scholar
• Parker M M, Parrillo J E. Septic shock-hemodynamics and pathogenesis. JAMA 1983; 250: 3324–7
   PubMed Web of Science ®Google Scholar
• Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet 1991; 337: 776–8
   PubMed Web of Science ®Google Scholar
• Fong Y, Marano M A, Moldawer L L, Wei H, Calvano S E, Kenney J S, et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990; 85: 1896–904
   PubMed Web of Science ®Google Scholar
• Kuhns D B, Alvord W G, Gallin J I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995; 171: 145–52
   PubMedGoogle Scholar
• Devière J, Content J, Denys C, Vandenbussche P, Schanden L, Wybran J, et al. Excessive bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11: 628–34
   PubMed Web of Science ®Google Scholar
• Khoruts A, Stahnke L, McClain C J, Logan G, Allen J I. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267–76
   PubMed Web of Science ®Google Scholar
• Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264–74
   PubMed Web of Science ®Google Scholar
• Kilbourn R G, Gross S S, Jubran A, Adams J, Griffith O W, Levi R, et al. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629–32
   PubMed Web of Science ®Google Scholar
• Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. Febs Letters 1990; 275: 87–90
   PubMed Web of Science ®Google Scholar
• Fong Y, Tracey K J, Moldawer L L, Hesse D G, Manogue K B, Kenney J S, et al. Antibodies to cachetin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170: 1627–33
   PubMed Web of Science ®Google Scholar
• Lopez-Talavera J C, Merrill W W, Groszmann R J. Tumor necrosis factor α: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995; 108: 761–7
   PubMed Web of Science ®Google Scholar
• Ohkawa F, Ikeda U, Kawasaki K, Kusano E, Igarashi M, Shimada K. Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol 1994; 266: H898–902
   PubMed Web of Science ®Google Scholar
• Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989; 172: 389–92
   PubMed Web of Science ®Google Scholar
• Pugh R NH, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60: 646–9
   PubMed Web of Science ®Google Scholar
• Tsai Y T, Lee F Y, Lin H C, Chang T T, Lay C S, Wang S S, et al. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg positive cirrhosis. Hepatology 1989; 10: 283–7
   PubMedGoogle Scholar
• Munford R S, Hall C L. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 1985; 48: 464–73
   PubMed Web of Science ®Google Scholar
• Fukuda I, Tanamoto K, Kanegasaki S, Yajima Y, Goto Y. Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro. Br J Exp Path 1989; 70: 267–74
   PubMedGoogle Scholar
• Curtiss S I, Eickmeyer D, Faire B, Mor E, Emre S, Sheiner P A, et al. Cytokine levels correlate with disease severity in patients with end-stage liver disease [abstract]. Hepatology 1994; 20: 191A
   PubMedGoogle Scholar
• Guarner C, Soriano G, Tomas A, Bulbena O, Novella M T, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139–43
   PubMed Web of Science ®Google Scholar
• Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364–75
   PubMed Web of Science ®Google Scholar
• Metha R, Gottstein J, Zeller W P, Lichtenberg R, Blei A T. Endotoxin and the hyperdynamic circulation of portal veinligated rats. Hepatology 1990; 12: 1152–6
   PubMedGoogle Scholar
• Lee F Y, Wang S S, Yang M CM, Tsai Y T, Wu S L, Lu R H, et al. Role of endotoxemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J Gastroenterol Hepatol 1995, in press
   Google Scholar
• Garcia-Tsao G, Albillos A, Barden G E, West B. Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993; 17: 1081–5
   PubMed Web of Science ®Google Scholar
• Sorell T W, Eamonn M, Quigley M, Gongliang J, Johnson T J, Rikkers L F. Bacterial translocation in the portal-hypertensive rats: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 1993; 104: 1722–6
   PubMedGoogle Scholar
• Garcia-Tsao G, Lee F Y, Barden G E, Cartun R, West A B. Bacterial translocation to mesenteric lymph nodes is increased in cirrhostic rats with ascites. Gastroenterology 1995; 108: 1835–41
   PubMed Web of Science ®Google Scholar
• Tartaglia L A, Rothe M, Hu Y F, Goeddel D V. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73: 213–6
   PubMed Web of Science ®Google Scholar
• Henriksen J H. Cirrhosis: ascites and hepatorenal syndrome. Recent advances in pathogenesis. J Hepatol 1995; 23(Suppl 1)25–30
   PubMedGoogle Scholar
• Sheron N, Lau J YN, Hofmann J, Alexander G JM, William R. Dose dependent increase in plasma interleukin-6 after recombinant tumor necrosis infusion in humans. Clin Exp Immunol 1990; 82: 427–8
   PubMed Web of Science ®Google Scholar
• Finkel M S, Oddis C V, Jacob J D, Watkins S C, Hattler B G, Simmons R L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9
   PubMed Web of Science ®Google Scholar